Evelyn Partners Investment Management Services’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$193K Buy
6,882
+800
+13% +$21.3K 0.02% 133
2025
Q4
$151K Sell
6,082
-3,878
-39% -$97.8K 0.02% 134
2025
Q3
$254K Sell
9,960
-7,682
-44% -$190K 0.03% 121
2025
Q2
$428K Hold
17,642
0.06% 102
2025
Q1
$447K Buy
17,642
+2,696
+18% +$70.5K 0.07% 96
2024
Q4
$397K Buy
+14,946
New +$405K 0.07% 96

Other funds holding PFE

Evelyn Partners Investment Management Services's PFE Position: Q1 2026 in Review

Evelyn Partners Investment Management Services increased its Pfizer (PFE) stake by 13% in Q1 2026, buying an estimated $21.3K and bringing the position to 6,882 shares worth $193K. The position accounts for 0.02% of the portfolio, ranked #133.

Evelyn Partners Investment Management Services first reported a position in PFE in Q4 2024 and has held it in 6 quarters since. The position peaked at $447K in Q1 2025. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Evelyn Partners Investment Management Services held 6,882 shares of Pfizer worth $193K as of Q1 2026.
  • Evelyn Partners Investment Management Services bought 800 Pfizer shares in Q1 2026, an estimated $21.3K.
  • Pfizer made up 0.02% of Evelyn Partners Investment Management Services's portfolio in Q1 2026, its #133 holding.
  • Evelyn Partners Investment Management Services first reported a position in Pfizer in Q4 2024 and has held it in 6 quarters since.
  • Evelyn Partners Investment Management Services's Pfizer position peaked at $447K in Q1 2025.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Evelyn Partners Investment Management Services's 13F filing for Q1 2026, filed 15 May 2026.